囊性纤维化和克罗恩病：英夫利昔单抗的成功治疗和长期缓解。
Cystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab.
机构信息
Gastroenterology and Endoscopy Unit, University of Parma, via Gramsci 14, 43100 Parma, Italy.
出版信息
World J Gastroenterol. 2010 Apr 21;16(15):1924-7. doi: 10.3748/wjg.v16.i15.1924.
Abstract
The association of cystic fibrosis and Crohn's disease (CD) is well known, but to date, there are very few cases in the literature of patients suffering from mucoviscidosis who have required treatment with infliximab. We report the case of a 23-year-old patient suffering from cystic fibrosis and severe CD treated successfully with infliximab without any infective complications or worsening of the pulmonary disease and with a long term (2 years) complete remission.
摘要
囊性纤维化和克罗恩病（CD）的关联是众所周知的，但迄今为止，文献中仅有极少数患有粘液化脓性疾病且需要英夫利昔单抗治疗的患者病例。我们报告了一例 23 岁的囊性纤维化患者，并发严重的 CD，成功地接受了英夫利昔单抗治疗，没有任何感染并发症，也没有使肺部疾病恶化，并且长期（2 年）完全缓解。
相似文献
1
Cystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab.囊性纤维化和克罗恩病：英夫利昔单抗的成功治疗和长期缓解。
World J Gastroenterol. 2010 Apr 21;16(15):1924-7. doi: 10.3748/wjg.v16.i15.1924.
2
Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report.英夫利昔单抗在一名对泛耐药铜绿假单胞菌呈囊性纤维化的克罗恩病患者中安全有效，并可诱导持续缓解及完全黏膜愈合：病例报告
J Crohns Colitis. 2014 Nov;8(11):1561-2. doi: 10.1016/j.crohns.2014.04.011. Epub 2014 May 15.
3
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.用于维持克罗恩病缓解的肿瘤坏死因子-α抗体。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
4
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.英夫利昔单抗可治愈克罗恩病患儿的肠道炎性病变并恢复其生长。
Dig Liver Dis. 2004 May;36(5):342-7. doi: 10.1016/j.dld.2003.12.014.
5
[Patients with cystic fibrosis become adults : Treatment hopes and disappointments].[囊性纤维化患者步入成年：治疗的希望与失望]
Internist (Berl). 2019 Jan;60(1):98-108. doi: 10.1007/s00108-018-0536-9.
6
Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.门诊队列中克罗恩病患者接受英夫利昔单抗治疗的长期缓解率
Can J Gastroenterol. 2009 May;23(5):348-52. doi: 10.1155/2009/180840.
7
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病：英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
8
A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.1例罕见的与英夫利昔单抗治疗狭窄型克罗恩病相关的游离性肠穿孔病例。
Korean J Gastroenterol. 2013 Sep;62(3):169-73. doi: 10.4166/kjg.2013.62.3.169.
9
[Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].英夫利昔单抗成功治疗无胃肠道表现的口面部克罗恩病
Korean J Gastroenterol. 2012 Jun 25;59(6):437-40. doi: 10.4166/kjg.2012.59.6.437.
10
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.英夫利昔单抗治疗克罗恩病的疗效、耐受性和应答预测因素：一项大型单中心经验。
J Crohns Colitis. 2012 Mar;6(2):143-53. doi: 10.1016/j.crohns.2011.07.011. Epub 2011 Aug 31.
引用本文的文献
1
Intestinal luminal anion transporters and their interplay with gut microbiome and inflammation.肠道腔阴离子转运体及其与肠道微生物群和炎症的相互作用。
Am J Physiol Cell Physiol. 2025 May 1;328(5):C1455-C1472. doi: 10.1152/ajpcell.00026.2025. Epub 2025 Mar 6.
2
Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.囊性纤维化患儿胃肠道表现的诊断与管理
Diagnostics (Basel). 2024 Jan 22;14(2):228. doi: 10.3390/diagnostics14020228.
3
Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis.儿童囊性纤维化患者无症状艰难梭菌定植的流行率、危险因素和后果。
J Cyst Fibros. 2023 Sep;22(5):884-887. doi: 10.1016/j.jcf.2022.12.014. Epub 2022 Dec 28.
4
Disrupted tight junctions in the small intestine of cystic fibrosis mice.囊性纤维化小鼠小肠中的紧密连接被破坏。
Cell Tissue Res. 2014 Jan;355(1):131-42. doi: 10.1007/s00441-013-1734-3. Epub 2013 Oct 30.
5
Metastatic bladder cancer presenting with persistent hematuria in young man with cystic fibrosis.患有囊性纤维化的年轻男性出现持续性血尿，诊断为转移性膀胱癌。
Case Rep Pulmonol. 2013;2013:831871. doi: 10.1155/2013/831871. Epub 2013 May 14.
6
Improvements in cystic fibrosis lung disease and airway inflammation associated with etanercept therapy for rheumatoid arthritis: a case report.与依那西普治疗类风湿关节炎相关的囊性纤维化肺病和气道炎症的改善：一例报告。
Lung. 2012 Oct;190(5):579-81. doi: 10.1007/s00408-012-9393-9. Epub 2012 Jun 4.
本文引用的文献
1
Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumor necrosis factor alpha.英夫利昔单抗（一种结合肿瘤坏死因子α的单克隆抗体）应用于一名囊性纤维化（CF）患者后，其肺功能和临床症状得到改善
Lung. 2009 May-Jun;187(3):149-52. doi: 10.1007/s00408-009-9138-6. Epub 2009 Feb 27.
2
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.用于维持克罗恩病缓解的肿瘤坏死因子-α抗体。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
3
Safety of biologic therapy.生物疗法的安全性。
Inflamm Bowel Dis. 2007 Jun;13(6):769-96. doi: 10.1002/ibd.20027.
4
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.阿奇霉素可选择性降低囊性纤维化气道上皮细胞中的肿瘤坏死因子α水平。
Antimicrob Agents Chemother. 2007 Mar;51(3):975-81. doi: 10.1128/AAC.01142-06. Epub 2007 Jan 8.
5
Abdominal manifestations of cystic fibrosis in older children and adults.大龄儿童及成人囊性纤维化的腹部表现
AJR Am J Roentgenol. 2006 Nov;187(5):1199-203. doi: 10.2214/AJR.05.0327.
6
Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.硫唑嘌呤可维持新诊断的儿童克罗恩病首次缓解状态。
Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67.
7
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.英夫利昔单抗联合硫唑嘌呤治疗激素依赖型克罗恩病患者：一项随机安慰剂对照试验。
Gastroenterology. 2006 Apr;130(4):1054-61. doi: 10.1053/j.gastro.2006.02.014.
8
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.欧洲关于克罗恩病诊断与管理的循证共识：当前管理措施
Gut. 2006 Mar;55 Suppl 1(Suppl 1):i16-35. doi: 10.1136/gut.2005.081950b.
9
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.儿童克罗恩病早期治疗中免疫调节剂使用的预测因素
J Clin Gastroenterol. 2006 Feb;40(2):145-8. doi: 10.1097/01.mcg.0000196192.49920.03.
10
Abdominal manifestations of cystic fibrosis in children.儿童囊性纤维化的腹部表现
Pediatr Radiol. 2006 Mar;36(3):233-40. doi: 10.1007/s00247-005-0049-2. Epub 2006 Jan 4.
Zotero 插件